Immunovant, Inc.

NASDAQ:IMVT

Biotechnology

Healthcare
$32.52 +2.00%

+$0.69 today

Market cap
$6.73B
Beta
0.79
P/E (TTM)
-14.3
EPS (TTM)
-$2.48
52W Low $14.32High $36.29

Volume 0.73M

Average 1.84M

Price history

Immunovant, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+42.69%

Period high

$44.96

Period low

$22.02

Latest

$32.52

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Nov 12, 2026Nov 12, 2026
10-QNov 9, 2026Nov 9, 2026
S-3ASRNov 9, 2026Nov 9, 2026
8-KNov 9, 2026Nov 9, 2026
4Oct 30, 2026Oct 30, 2026
4Oct 23, 2026Oct 23, 2026
4Oct 9, 2026Oct 9, 2026
4Oct 9, 2026Oct 9, 2026
4Oct 9, 2026Oct 9, 2026
4Oct 5, 2026Oct 5, 2026
4Sep 25, 2026Sep 25, 2026
8-KSep 3, 2026Sep 3, 2026
4Aug 28, 2026Aug 28, 2026
4Aug 21, 2026Aug 21, 2026
SC 13G/AAug 14, 2026Aug 14, 2026

Competitors

Who does Immunovant, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about IMVT's filings, answered from its disclosures.

What is the latest IMVT filing?

The latest filing shown is 4 dated Nov 12, 2026.

How many recent filings does IMVT have?

Intrinsic Alpha currently shows 20 recent filings for IMVT.